Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 8M | 7M | 7M | 8M |
| Cost of revenue | 6M | 5M | 4M | 7M |
| Gross profit | 1M | 1M | 2M | 790,675 |
| Research and development | 970,859 | 927,412 | 2M | 651,302 |
| Net income | −23M | −14M | −24M | −28M |
| Earnings per share | −1.46 | −4.40 | −14.58 | −20.34 |
| Earnings per share, diluted | −1.46 | −4.40 | −14.58 | −20.34 |
| Weighted average shares | 16M | 3M | 2M | 1M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 90M | 6M | 3M | 8M | 23M |
| Receivables | — | 1M | 573,390 | 649,612 | — | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −24M | −12M | −19M | −16M |
| Share-based compensation | 1M | 1M | 2M | 3M |
| Capital expenditure | 923,037 | 167,257 | 490,391 | 79,713 |
| Investing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Inventory | — | 4M | 2M | 2M | — | — |
| Current assets | — | 100M | 9M | 7M | — | — |
| Property, plant and equipment | — | 1M | 529,542 | 680,801 | — | — |
| Total assets | — | 101M | 10M | 8M | — | — |
| Current liabilities | — | 5M | 5M | 7M | — | — |
| Total liabilities | — | 5M | 6M | 8M | — | — |
| Equity | — | 97M | 5M | 407,716 | 11M | 35M |
| −853,391 |
| −23,314 |
| −379,577 |
| 768,655 |
| Financing cash flow | 109M | 15M | 14M | −48,098 |